Skip to main content

Canton Barry's Form 4 filing

Ginkgo Bioworks Holdings, Inc. (DNA) · filed Jul 30, 2026

Accession no.
0001628280-26-051089
Filed
Jul 30, 2026, 4:28 PM ET
Trade date
Jul 28, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 0 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Canton BarryCIK 000188275610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 28, 2026Class A Common StockAGrant or awardAcquired+35,736––35,736DirectDuplicate filing
Jul 28, 2026Class A Common StockAGrant or awardAcquired+117,135––117,135DirectDuplicate filing
Jul 28, 2026Class A Common StockAGrant or awardAcquired+39,038––39,038IndirectDuplicate filing
Jul 28, 2026Class A Common StockAGrant or awardAcquired+127,423––127,423IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)